1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Blue Belt Technologies

Anonymous board for Blue Belt Technologies


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    1
    Views:
    7,258
  2. Anonymous
    Replies:
    0
    Views:
    4,349
  3. Anonymous
    Replies:
    4
    Views:
    6,653
  4. Anonymous
    Replies:
    4
    Views:
    4,685
  5. Anonymous
    Replies:
    0
    Views:
    3,842
  6. dspinerep
    Replies:
    1
    Views:
    3,838
  7. Anonymous
    Replies:
    0
    Views:
    2,852
  8. Anonymous
    Replies:
    0
    Views:
    2,492
  9. Anonymous
    Replies:
    0
    Views:
    2,720
  10. Anonymous
    Replies:
    3
    Views:
    3,207
  11. Anonymous
    Replies:
    6
    Views:
    3,690
  12. Anonymous
    Replies:
    3
    Views:
    3,466
  13. Anonymous
    Replies:
    0
    Views:
    2,541
  14. Anonymous
    Replies:
    1
    Views:
    2,457
  15. Anonymous
    Replies:
    2
    Views:
    3,144
  16. Anonymous
    Replies:
    2
    Views:
    2,914
  17. Anonymous
    Replies:
    0
    Views:
    2,607
  18. Anonymous
    Replies:
    5
    Views:
    4,158
  19. Anonymous
    Replies:
    1
    Views:
    3,914
  20. Anonymous
    Replies:
    1
    Views:
    2,856

Thread Display Options

Loading...